Government urged to clarify consulting/lecturing fees

Pharmaceutical companies are hesitating to hold non-commercial consulting and/or lecturing sessions under the new rebate ban guidelines.

However, due to the unclear relevant regulation, companies have called on the government to clarify the scope of consulting/lecturing fees.

In a recent information session on December 6, the health ministry said that the fees should be regulated under a ...